penicillanic acid has been researched along with Body Weight in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheatham, SC; Chung, EK; Fleming, MR; Healy, DP; Kays, MB; Shea, KM | 1 |
| Chen, R; Qian, CY; Qian, Q; Sun, MR; Wang, LY; Wang, ML; Zou, SL | 1 |
| Calvo, G; Fernández, J; Llauradó-Serra, M; Martín-Loeches, I; Pontes, C; Rodríguez, A; Soy, D; Torres, A; Ulldemolins, M; Vaquer, S | 1 |
| Cao, D; Cao, Y; Chen, C; Chen, Y; Li, Q; Li, Z; Shi, W; Wang, Y; Wu, D; Zhu, Y | 1 |
| Alexander, JJ; Gobburu, JV; Imoisili, MA; Korth-Bradley, JM; Tornøe, CW; Tworzyanski, JJ | 1 |
| Aguirre, C; Barreiro, G; Ruiz-Irastorza, G | 1 |
2 trial(s) available for penicillanic acid and Body Weight
| Article | Year |
|---|---|
Population pharmacokinetics and pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in obese and nonobese patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Body Mass Index; Body Weight; Computer Simulation; Creatinine; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Models, Biological; Monte Carlo Method; Obesity; Penicillanic Acid; Piperacillin; Tazobactam | 2015 |
Population pharmacokinetics of piperacillin/tazobactam in neonates and young infants.
Topics: Age Factors; Anti-Bacterial Agents; Body Weight; China; Computer Simulation; Drug Dosage Calculations; Drug Monitoring; Female; Humans; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Male; Models, Biological; Nonlinear Dynamics; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2013 |
4 other study(ies) available for penicillanic acid and Body Weight
| Article | Year |
|---|---|
Population Pharmacokinetics and Pharmacodynamics of Piperacillin/Tazobactam in Patients with Nosocomial Infections.
Topics: Anti-Bacterial Agents; Body Weight; Cross Infection; Female; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam | 2016 |
Piperacillin population pharmacokinetics in critically ill patients with multiple organ dysfunction syndrome receiving continuous venovenous haemodiafiltration: effect of type of dialysis membrane on dosing requirements.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Body Weight; Chromatography, Liquid; Critical Illness; Female; Hemodiafiltration; Humans; Infusions, Intravenous; Male; Mass Spectrometry; Microbial Sensitivity Tests; Middle Aged; Multiple Organ Failure; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Plasma; Prospective Studies; Tertiary Care Centers; Young Adult | 2016 |
Optimising piperacillin/tazobactam dosing in paediatrics.
Topics: Age Factors; Anti-Bacterial Agents; Body Weight; Child; Child, Preschool; Computer Simulation; Demography; Drug Labeling; Humans; Infant; Metabolic Clearance Rate; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Regression Analysis; Tissue Distribution | 2007 |
Reversible bone marrow depression by high-dose piperacillin/tazobactam.
Topics: Adolescent; Body Weight; Bone Marrow Diseases; Drug Therapy, Combination; Female; Fever; Humans; Neutropenia; Pancytopenia; Penicillanic Acid; Piperacillin; Tazobactam; Weight Loss | 1996 |